Exicure, Inc.

XCUR Nasdaq SEC CIK 1698530
Follow Exicure Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0
Net income $642K +126.3% vs same quarter last year
EPS, diluted $0.10 +125.6% vs same quarter last year
Operating cash flow −$492K +86.1% vs same quarter last year
Revenue by quarter
$0
$0
$0
$0
$0
$0
$0
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income11 fiscal years
  • Revenue
  • Net income
−$75M−$50M−$25M$0$25M$50MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$0−$4.9M
FY24$500K−$9.7M
FY23$0−$16.9M
FY22$28.8M−$2.6M
FY21-−$64.1M
FY20$16.6M−$24.7M
FY19$1.3M−$26.3M
FY18$118K−$22.4M
FY17$9.7M−$11M
FY16$1M−$16.9M
FY15--
MarginsShare of revenue
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24−2446.4%−1940.2%
FY23--
FY22−6.4%−9%
FY21--
FY20−153.1%−148.5%
FY19−2053.8%−2029.6%
FY18−18490.7%−18994.1%
FY17−107.1%−113.3%
FY16−1560%−1635.2%
FY15--
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0$20MFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$8.6M
FY24−$2.9M
FY23−$10.4M
FY22−$35.7M
FY21−$35.8M
FY20−$42.4M
FY19$235K
FY18−$19.6M
FY17−$20.7M
FY16−$5.4M
FY15-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Exicure
  • Healthcare median
−20000%−15000%−10000%−5000%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearExicureHealthcare median
FY25-−30.6%
FY24−1940.2%−47%
FY23-−58%
FY22−9%−80.4%
FY21-−71.9%
FY20−148.5%−62.2%
FY19−2029.6%−46.3%
FY18−18994.1%−49.6%
FY17−113.3%−45.9%
FY16−1635.2%−36%
FY15-−38.4%